COMPLEMENT AND PROPERDIN: BIOLOGIC AND CLINICAL IMPORTANCERUDDY S.1975; ORTHOP. CLIN. N. AMER.; U.S.A.; DA. 1975; VOL. 6; NO 3; PP. 609-617; BIBL. 15 REF.Article

The American College of Rheumatology as a professional society : An oxymoron ?RUDDY, S.Arthritis and rheumatism. 1996, Vol 39, Num 6, pp 887-890, issn 0004-3591Conference Paper

MODULATION OF C3B HEMOLYTIC ACTIVITY BY A PLASMA PROTEIN DISTINCT FROM C3B INACTIVATOR.WHALEY K; RUDDY S.1976; SCIENCE; U.S.A.; DA. 1976; VOL. 193; NO 4257; PP. 1011-1013; BIBL. 15 REF.Article

MONOCYTE COMPLEMENT STIMULATOR: A T-LYMPHOCYTE PRODUCT WHICH STIMULATES SYNTHESIS OF THE SECOND COMPLEMENT COMPONENT (C2)LITTMAN BH; RUDDY S.1979; CELL. IMMUNOL.; USA; DA. 1979; VOL. 43; NO 2; PP. 388-397; BIBL. 25 REF.Article

ACTIVATION OF THE COMPLEMENT SYSTEM IN RHEUMATOID SYNOVITIS = ACTIVATION DU SYSTEME DU COMPLEMENT DANS LA SYNOVITE RHUMATOIDERUDDY S; AUSTEN KF.1973; FEDER. PROC.; U.S.A.; DA. 1973; VOL. 32; NO 2; PP. 134-137; BIBL. 34REF.Serial Issue

THE ROLE OF IMMUNOGLOBULINS IN ALTERNATIVE PATHWAY ACTIVATION BY ZYMOSAN. II: THE EFFECT OF IGG ON THE KINETICS OF THE ALTERNATIVE PATHWAYSCHENKEIN HA; RUDDY S.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 1; PP. 11-15; BIBL. 18 REF.Article

THE ROLE OF IMMUNOGLOBULINS IN ALTERNATIVE COMPLEMENT PATHWAY ACTIVATION BY ZYMOSAN. I: HUMAN IGG WITH SPECIFICITY FOR ZYMOSAN ENHANCES ALTERNATIVE PATHWAY ACTIVATION BY ZYMOSANSCHENKEIN HA; RUDDY S.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 1; PP. 7-10; BIBL. 20 REF.Article

ENHANCING ROLE OF IGG IN LYSIS OF RABBIT ERYTHROCYTES BY THE ALTERNATIVE PATHWAY OF HUMAN COMPLEMENTNELSON B; RUDDY S.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 122; NO 5; PP. 1994-1999; BIBL. 21 REF.Article

PRODUCTION OF THE SECOND COMPONENT OF COMPLEMENT BY HUMAN MONOCYTES: STIMULATION BY ANTIGEN-ACTIVATED LYMPHOCYTES OR LYMPHOKINES.LITTMAN BH; RUDDY S.1977; J. EXPER. MED.; U.S.A.; DA. 1977; VOL. 145; NO 5; PP. 1344-1352; BIBL. 13 REF.Article

MODULATION OF THE ALTERNATIVE COMPLEMENT PATHWAY BY BETA 1H GLOBULIN.WHALEY K; RUDDY S.1976; J. EXPER. MED.; U.S.A.; DA. 1976; VOL. 144; NO 5; PP. 1147-1163; BIBL. 1 P. 1/2Article

RELATIVE IMPORTANCE OF C3B INACTIVATOR AND BETA 1H GLOBULIN IN THE MODULATION OF THE PROPERDIN AMPLIFICATION LOOP IN SYSTEMIC LUPUS ERYTHEMATOSUSWHALEY K; SCHUR PH; RUDDY S et al.1979; CLIN. EXPER. IMMUNOL.; GBR; DA. 1979; VOL. 36; NO 3; PP. 408-414; BIBL. 24 REF.Article

C3B INACTIVATOR IN THE RHEUMATIC DISEASES. MEASUREMENT BY RADIAL IMMUNODIFFUSION AND BY INHIBITION OF FORMATION OF PROPERDIN PATHWAY C3 CONVERTASE = INACTIVATEUR DU C3B DANS LES MALADIES RHUMATISMALES. MESURE PAR IMMUNODIFFUSION RADIALE ET PAR INHIBITION DE LA FORMATION DE C3 CONVERTASE DE LA VOIE DE LA PROPERDINEWHALEY K; SCHUR PH; RUDDY S et al.1976; J. CLIN. INVEST.; U.S.A.; DA. 1976; VOL. 57; NO 6; PP. 1554-1563; BIBL. 2 P.Article

REACTION MECHANISMS OF NASCENT C5AO (REACTIVE LYSIS) I. REACTION CHARACTERISTICS FOR PRODUCTION OF EC5AO AND LYSIS BY C8 AND C9GOLDMAN JN; RUDDY S; AUSTEN KF et al.1972; J. IMMUNOL.; U.S.A.; DA. 1972; VOL. 109; NO 2; PP. 353-359; BIBL. 14REF.Serial Issue

THE COMPLEMENT SYSTEM OF MAN. (FIRST OF FOUR PARTS) = LE SYSTEME DU COMPLEMENT CHEZ L'HOMME. IRUDDY S; GIGLI I; AUSTEN KF et al.1972; NEW ENGL. J. MED.; U.S.A.; DA. 1972; VOL. 287; NO 10; PP. 489-495; BIBL. 1P.Serial Issue

THE COMPLEMENT SYSTEM OF MAN. II = LE SYSTEME DU COMPLEMENT CHEZ L'HOMME. IIRUDDY S; GIGLI I; AUSTEN KF et al.1972; NEW ENGL. J. MED.; U.S.A.; DA. 1972; VOL. 287; NO 11; PP. 545-549; BIBL. 1 P.Serial Issue

SPECIFICITY OF C3 RECEPTORS THAT MEDIATE PHAGOCYTOSIS BY RAT PERITONEAL MAST CELLSVRANIAN G JR; CONRAD DH; RUDDY S et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 6; PP. 2302-2306; BIBL. 33 REF.Article

DEPRESSED SYNOVIAL FLUID LEVELS OF PROPERDIN AND PROPERDIN FACTOR B IN PATIENTS WITH RHEUMATOID ARTHRITISRUDDY S; FEARON DT; AUSTEN KF et al.1975; ARTHRIT. AND RHEUMATISM; U.S.A.; DA. 1975; VOL. 18; NO 4; PP. 289-295; BIBL. 37 REF.Article

THE COMPLEMENT SYSTEM OF MAN. IV. = LE SYSTEME DU COMPLEMENT CHEZ L'HOMME. IVRUDDY S; GIGLI I; AUSTEN KF et al.1972; NEW ENGL. J. MED.; U.S.A.; DA. 1972; VOL. 287; NO 13; PP. 642-646; BIBL. 1 P. 1/2Serial Issue

ASSAY OF COMPLEMENT C1, C4, C2, C3 AND C9 IN WHOLE RAT SERUMCALDWELL JR; RUDDY S; AUSTEN KF et al.1972; INTERNATION. ARCH. ALLERGY APPL. IMMUNOL.; SWITZ.; DA. 1972; VOL. 43; NO 6; PP. 887-897; BIBL. 1P.1/2Serial Issue

FUNCTIONAL AND PARTIAL CHEMICAL CHARACTERIZATION OF THE CARBOHYDRATE MOIETIES OF THE IGE RECEPTOR ON RAT BASOPHILIC LEUKEMIA CELLS AND RAT MAST CELLSPECOUD AR; RUDDY S; CONRAD DH et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 4; PP. 1624-1629; BIBL. 33 REF.Article

ACUTE ANAPHYLAXIS ASSOCIATED WITH SERUM COMPLEMENT DEPLETION.TANNENBAUM H; RUDDY S; SCHUR PH et al.1975; J. ALLERGY CLIN. IMMUNOL.; U.S.A.; DA. 1975; VOL. 56; NO 3; PP. 226-234; BIBL. 1 P.Article

ALTERNATE COMPLEMENT PATHWAY. FACTORS INVOLVED IN COBRA VENOM FACTOR (COVF) ACTIVATION OF THE THIRD COMPONENT OF COMPLEMENT (C3)HUNSICKER LG; RUDDY S; AUSTEN KF et al.1973; J. IMMUNOL.; U.S.A.; DA. 1973; VOL. 110; NO 1; PP. 128-138; BIBL. 37REF.Serial Issue

THE COMPLEMENT SYSTEM OF MAN. III = LE SYSTEME DU COMPLEMENT CHEZ L'HOMME. IIIRUDDY S; GIGLI I; AUSTEN KF et al.1972; NEW ENGL. J. MED.; U.S.A.; DA. 1972; VOL. 287; NO 12; PP. 592-596; BIBL. 1/2 P.Serial Issue

LOCALIZATION OF THE RECEPTORS FOR ACTIVATED COMPLEMENT ON THE VISCERAL EPITHELIAL CELLS OF THE HUMAN RENAL GLOMERULUS BY IMMUNOENZYMATIC MICROSCOPYCARLO JR; RUDDY S; CONWAY AF et al.1981; AM. J. CLIN. PATHOL.; ISSN 0002-9173; USA; DA. 1981; VOL. 75; NO 1; PP. 23-27; BIBL. 22 REF.Article

CHEMOTACTIC ACTIVITY DERIVED FROM INTERACTION OF FACTORS D AND B OF THE PROPERDIN PATHWAY WITH COBRA VENOM FACTOR OR C3BRUDDY S; AUSTEN KF; GOETZL EJ et al.1975; J. CLIN. INVEST.; U.S.A.; DA. 1975; VOL. 55; NO 3; PP. 587-592; BIBL. 26REF.Article